Blood News and Research

RSS

Study explores the effect of age-associated B cells on COVID-19 vaccine-induced immunity

In a new study, a team of researchers explored the effect of immune checkpoint blockade (ICB)-induced expansion of age-associated B cells (ABCs) on COVID-19 vaccine-derived humoral immunity in patients with cancer and inborn errors of immunity (IEI).

22 Sep 2022

Scientists uncover key details of an immune-cell process that underlies excessive inflammation

A team led by Scripps Research scientists has uncovered key details of an immune-cell process that frequently underlies excessive inflammation in the body.

22 Sep 2022

How frequent was SARS-CoV-2 and malaria co-infection during the first wave of the pandemic?

Researchers determined the prevalence of circulating SARS-CoV-2 variants and the frequency of co-occurrence of COVID-19 and malaria in Burkina Faso, West Africa.

22 Sep 2022

An unusual case of Monkeypox virus transmission by needlestick injury

In a recent study published in the U.S. Centers for Disease Control and Prevention journal Emerging Infectious Diseases, researchers described an unusual case of patient-to-healthcare worker (HCW) monkeypox virus (MPXV) transmission via a needlestick injury that occured in Brazil.

21 Sep 2022

Cutting-edge technology uses MRI to diagnose patients with heart failure in record time

Researchers at the University of East Anglia have developed cutting-edge technology to diagnose patients with heart failure in record time.

21 Sep 2022

Cardiovascular disease risk factors are largely the same for women and men, study shows

For women and men, the risk factors for cardiovascular disease are largely the same, an extensive global study involving University of Gothenburg shows.

21 Sep 2022

Better physical fitness reduces frailty risk in patients with chronic lymphocytic leukemia

Increased levels of exercise could help reduce frailty in patients with the most common form of leukemia, chronic lymphocytic (CLL), according to new research from the University of Surrey.

21 Sep 2022

Metabolic differences between early birds and night owls could help predict diabetes, heart disease risk

Are you an early bird or a night owl? Our activity patterns and sleep cycles could influence our risk of diseases, such as type 2 diabetes and heart disease.

21 Sep 2022

Large clinical trial compares four drugs commonly used to treat type 2 diabetes

In a large clinical trial that directly compared four drugs commonly used to treat type 2 diabetes, researchers found that insulin glargine and liraglutide performed the best of four medications approved by the U.S. Food and Drug Administration to maintain blood glucose levels in the recommended range.

21 Sep 2022

Synthetic mucin gels against HIV-1 and HSV-2 transmission

In a new study, researchers assessed the effectiveness of synthetic mucin gels in the inhibition of human immunodeficiency virus-1 (HIV-1) and herpes simplex virus-2 (HSV-2) Transmission.

21 Sep 2022

Genome-based microbiome signature associated with the severity and prognosis of COVID-19 in hospitalized patients

Researchers evaluated the association between guild-level microbiome signature and the severity and prognosis of SARS-CoV-2 infections by a genome-level metagenomic analysis.

21 Sep 2022

Study reveals increased immunity evasion by Omicron BA.2.75.2

In a recent study posted to the bioRxiv* preprint server, researchers from ETH Zurich, Imperial College London, and Karolinska Institutet identified increased resistance to antibody-mediated neutralization by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sublineage BA.2.75.2.

21 Sep 2022

Study: Life-threatening blood clots remain for at least 49 weeks after COVID-19

COVID-19 infection increases the risk of potentially life-threatening blood clots for at least 49 weeks, according to a new study of health records of 48 million unvaccinated adults from the first wave of the pandemic.

21 Sep 2022

Researchers successfully deliver a common blood pressure drug directly to cells’ ‘power plants’

In a study using lab-grown cells, Johns Hopkins Medicine researchers specializing in aging report they have successfully delivered a common blood pressure drug directly to the inner membrane of mitochondria, the "power plants" in the cells of humans, animals, plants and most other organisms.

20 Sep 2022

Combination of three existing drugs extends survival in mouse models of lethal brain cancer

A Ludwig Cancer Research study has identified a combination of three existing drugs that significantly extends survival in mouse models of the lethal brain cancer glioblastoma multiforme (GBM).

20 Sep 2022

No adverse affect on sperm quality 6 to 14 months post BNT162b2 COVID vaccine

A study published in the journal Gamete Biology demonstrates that the mRNA-based coronavirus disease 2019 (COVID-19) vaccine developed by Pfizer/BioNTech is not detrimental to sperm health over a long period post-vaccination.

20 Sep 2022

Study reveals mental health burden in the Flint community five years after water crisis

Data from the largest mental health survey of the Flint, Michigan community indicate that one in five adults, or roughly 13,600 people, were estimated to have clinical depression, and one in four, or 15,000 people, were estimated to have PTSD five years after the water crisis began.

20 Sep 2022

Healthy people with high cholesterol don't stand to benefit from statins, research says

About 40 million adults in the United States regularly take statins to lower their cholesterol levels and reduce their risk of heart disease and stroke, according to American Heart Association data from 2020.

20 Sep 2022

Cutting protein intake can help control obesity, diabetes and hypertension

Cutting protein intake can help control metabolic syndrome and some of its main symptoms, such as obesity, diabetes and high blood pressure (hypertension), according to a study conducted by researchers in Brazil and Denmark to compare the effects of protein and calorie restriction diets in humans.

20 Sep 2022

New device for diagnosing bone fragility approved for marketing in the Europe

A new device for diagnosing bone fragility invented by the University Hospitals of Geneva and the University of Geneva has been approved for marketing in the European Economic Area and Switzerland.

20 Sep 2022

Blood News and Research

Study explores the effect of age-associated B cells on COVID-19 vaccine-induced immunity

Scientists uncover key details of an immune-cell process that underlies excessive inflammation

How frequent was SARS-CoV-2 and malaria co-infection during the first wave of the pandemic?

An unusual case of Monkeypox virus transmission by needlestick injury

Cutting-edge technology uses MRI to diagnose patients with heart failure in record time

Cardiovascular disease risk factors are largely the same for women and men, study shows

Better physical fitness reduces frailty risk in patients with chronic lymphocytic leukemia

Metabolic differences between early birds and night owls could help predict diabetes, heart disease risk

Large clinical trial compares four drugs commonly used to treat type 2 diabetes

Synthetic mucin gels against HIV-1 and HSV-2 transmission

Genome-based microbiome signature associated with the severity and prognosis of COVID-19 in hospitalized patients

Study reveals increased immunity evasion by Omicron BA.2.75.2

Study: Life-threatening blood clots remain for at least 49 weeks after COVID-19

Researchers successfully deliver a common blood pressure drug directly to cells’ ‘power plants’

Combination of three existing drugs extends survival in mouse models of lethal brain cancer

No adverse affect on sperm quality 6 to 14 months post BNT162b2 COVID vaccine

Study reveals mental health burden in the Flint community five years after water crisis

Healthy people with high cholesterol don't stand to benefit from statins, research says

Cutting protein intake can help control obesity, diabetes and hypertension

New device for diagnosing bone fragility approved for marketing in the Europe

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News